Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude

G. Banfi, M. Marinelli, G. S. Roi, A. Colombini, M. Pontillo, M. Giacometti, S. Wade

Research output: Contribution to journalArticle

Abstract

Human growth hormone (hGH) characteristically increases during physical exercise. In sports medicine, hGH changes have mostly been described in short-term performances under standardized laboratory procedures. We studied hGH and insulin-like growth factor I (IGF-I) under field conditions in 7 runners performing a marathon at 4000 m of altitude, to study the hormonal changes under extreme endurance effort and to evaluate the release of 22 kDa and 20 kDa monomers under these conditions, in comparison with a control group. The blood samples were taken at sea level, after 1 week of acclimatization, immediately after the run, and after a recovery of 24 h from the marathon. hGH was quantified by using a polyclonal method, a 22 kDa specific monoclonal method and a monoclonal method recognizing both 22 kDa and 20 kDa isoforms. A significant increase in hGH was noted using all methods after the marathon, followed by a significant decrease after recovery. Significant differences between athletes and controls were found only for the measurement after the marathon. No statistically reliable decrease of IGF-I as observed in athletes and controls. We obtained more limited hGH rises than previously described in athletes; the importance of lactate levels indicates that the use of physical exercise as a stimulation test for hGH should be closely standardized. The 20 kDa monomer and other hGH molecular forms played a limited role in the hormone increase: in our experience, elevation of hGH in heavy exercise corresponds mostly to the 22 kDa isoform. We suggest that the evaluation of hGH elevation in sports medicine could be accurately performed using specific 22 kDa monoclonal assays.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalGrowth Regulation
Volume4
Issue number2
Publication statusPublished - 1994

Fingerprint

Human Growth Hormone
Insulin-Like Growth Factor I
Athletes
Growth Hormone
Sports Medicine
Exercise
Protein Isoforms
Acclimatization
Oceans and Seas
Lactic Acid
Hormones
Control Groups

Keywords

  • Aerobic exercise
  • Altitude
  • Athletes
  • Growth hormone
  • Insulin-like growth factor-I

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Banfi, G., Marinelli, M., Roi, G. S., Colombini, A., Pontillo, M., Giacometti, M., & Wade, S. (1994). Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. Growth Regulation, 4(2), 82-86.

Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. / Banfi, G.; Marinelli, M.; Roi, G. S.; Colombini, A.; Pontillo, M.; Giacometti, M.; Wade, S.

In: Growth Regulation, Vol. 4, No. 2, 1994, p. 82-86.

Research output: Contribution to journalArticle

Banfi, G, Marinelli, M, Roi, GS, Colombini, A, Pontillo, M, Giacometti, M & Wade, S 1994, 'Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude', Growth Regulation, vol. 4, no. 2, pp. 82-86.
Banfi G, Marinelli M, Roi GS, Colombini A, Pontillo M, Giacometti M et al. Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. Growth Regulation. 1994;4(2):82-86.
Banfi, G. ; Marinelli, M. ; Roi, G. S. ; Colombini, A. ; Pontillo, M. ; Giacometti, M. ; Wade, S. / Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. In: Growth Regulation. 1994 ; Vol. 4, No. 2. pp. 82-86.
@article{e311001a37334a6fa718c798863cb5c5,
title = "Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude",
abstract = "Human growth hormone (hGH) characteristically increases during physical exercise. In sports medicine, hGH changes have mostly been described in short-term performances under standardized laboratory procedures. We studied hGH and insulin-like growth factor I (IGF-I) under field conditions in 7 runners performing a marathon at 4000 m of altitude, to study the hormonal changes under extreme endurance effort and to evaluate the release of 22 kDa and 20 kDa monomers under these conditions, in comparison with a control group. The blood samples were taken at sea level, after 1 week of acclimatization, immediately after the run, and after a recovery of 24 h from the marathon. hGH was quantified by using a polyclonal method, a 22 kDa specific monoclonal method and a monoclonal method recognizing both 22 kDa and 20 kDa isoforms. A significant increase in hGH was noted using all methods after the marathon, followed by a significant decrease after recovery. Significant differences between athletes and controls were found only for the measurement after the marathon. No statistically reliable decrease of IGF-I as observed in athletes and controls. We obtained more limited hGH rises than previously described in athletes; the importance of lactate levels indicates that the use of physical exercise as a stimulation test for hGH should be closely standardized. The 20 kDa monomer and other hGH molecular forms played a limited role in the hormone increase: in our experience, elevation of hGH in heavy exercise corresponds mostly to the 22 kDa isoform. We suggest that the evaluation of hGH elevation in sports medicine could be accurately performed using specific 22 kDa monoclonal assays.",
keywords = "Aerobic exercise, Altitude, Athletes, Growth hormone, Insulin-like growth factor-I",
author = "G. Banfi and M. Marinelli and Roi, {G. S.} and A. Colombini and M. Pontillo and M. Giacometti and S. Wade",
year = "1994",
language = "English",
volume = "4",
pages = "82--86",
journal = "Growth Regulation",
issn = "0956-523X",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude

AU - Banfi, G.

AU - Marinelli, M.

AU - Roi, G. S.

AU - Colombini, A.

AU - Pontillo, M.

AU - Giacometti, M.

AU - Wade, S.

PY - 1994

Y1 - 1994

N2 - Human growth hormone (hGH) characteristically increases during physical exercise. In sports medicine, hGH changes have mostly been described in short-term performances under standardized laboratory procedures. We studied hGH and insulin-like growth factor I (IGF-I) under field conditions in 7 runners performing a marathon at 4000 m of altitude, to study the hormonal changes under extreme endurance effort and to evaluate the release of 22 kDa and 20 kDa monomers under these conditions, in comparison with a control group. The blood samples were taken at sea level, after 1 week of acclimatization, immediately after the run, and after a recovery of 24 h from the marathon. hGH was quantified by using a polyclonal method, a 22 kDa specific monoclonal method and a monoclonal method recognizing both 22 kDa and 20 kDa isoforms. A significant increase in hGH was noted using all methods after the marathon, followed by a significant decrease after recovery. Significant differences between athletes and controls were found only for the measurement after the marathon. No statistically reliable decrease of IGF-I as observed in athletes and controls. We obtained more limited hGH rises than previously described in athletes; the importance of lactate levels indicates that the use of physical exercise as a stimulation test for hGH should be closely standardized. The 20 kDa monomer and other hGH molecular forms played a limited role in the hormone increase: in our experience, elevation of hGH in heavy exercise corresponds mostly to the 22 kDa isoform. We suggest that the evaluation of hGH elevation in sports medicine could be accurately performed using specific 22 kDa monoclonal assays.

AB - Human growth hormone (hGH) characteristically increases during physical exercise. In sports medicine, hGH changes have mostly been described in short-term performances under standardized laboratory procedures. We studied hGH and insulin-like growth factor I (IGF-I) under field conditions in 7 runners performing a marathon at 4000 m of altitude, to study the hormonal changes under extreme endurance effort and to evaluate the release of 22 kDa and 20 kDa monomers under these conditions, in comparison with a control group. The blood samples were taken at sea level, after 1 week of acclimatization, immediately after the run, and after a recovery of 24 h from the marathon. hGH was quantified by using a polyclonal method, a 22 kDa specific monoclonal method and a monoclonal method recognizing both 22 kDa and 20 kDa isoforms. A significant increase in hGH was noted using all methods after the marathon, followed by a significant decrease after recovery. Significant differences between athletes and controls were found only for the measurement after the marathon. No statistically reliable decrease of IGF-I as observed in athletes and controls. We obtained more limited hGH rises than previously described in athletes; the importance of lactate levels indicates that the use of physical exercise as a stimulation test for hGH should be closely standardized. The 20 kDa monomer and other hGH molecular forms played a limited role in the hormone increase: in our experience, elevation of hGH in heavy exercise corresponds mostly to the 22 kDa isoform. We suggest that the evaluation of hGH elevation in sports medicine could be accurately performed using specific 22 kDa monoclonal assays.

KW - Aerobic exercise

KW - Altitude

KW - Athletes

KW - Growth hormone

KW - Insulin-like growth factor-I

UR - http://www.scopus.com/inward/record.url?scp=0028239685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028239685&partnerID=8YFLogxK

M3 - Article

C2 - 7950906

AN - SCOPUS:0028239685

VL - 4

SP - 82

EP - 86

JO - Growth Regulation

JF - Growth Regulation

SN - 0956-523X

IS - 2

ER -